The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Advances Day 2019 | Improving outcomes for myelofibrosis
Ruben Mesa
• 15 Nov 2019
Ruben Mesa, MD, FACP, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, gives an overview of the issues which must be overcome to improve patient outcomes for myelofibrosis. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
